METHOCARBAMOL TABLE

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC with CAGE code 1UNB0 for the procurement of five units of methocarbamol tablets (NSN 6505006601601, NDC 51407-0467-05) at a total contract value of $63.30. The order was issued on July 14, 2026, and requires delivery by July 29, 2026, to Fort Campbell, Kentucky, under FOB destination terms where the contractor bears all shipping costs and assumes risk until receipt. The product must be shipped via traceable means excluding parcel post, with all packaging and documentation marked using the identification numbers from the order and a traceable control number. The contractor is certified as a Small Business, Small Disadvantaged Business, and Women-Owned Small Business, triggering compliance obligations under FAR Part 19. Inspection and acceptance occur at the delivery location by authorized government personnel, contingent on conformity to contract specifications and adherence to DLA pharmaceutical procurement policies referenced through the underlying basic contract. Payment is processed through the Defense Finance and Accounting Service in Columbus, Ohio, using voucher-based systems with payment code SL4701, and appropriation data is tracked under code 97X4930 5CBX 001 2620 S33189. The contracting officer is Lisa Quinn, with Shairy M. Cartagena designated as the issuing office contact for administrative coordination. No specific packaging, preservation, or labeling standards beyond traceability and marking requirements are prescribed, and no MIL-STDs or detailed quality criteria beyond contractual compliance are cited. The award reflects a straightforward, low-value pharmaceutical delivery without option quantities, modification history, or negotiated evaluation factors, consistent with a routine procurement under an existing indefinite-delivery vehicle.